Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 The proportion of B (CD19) and T (CD3) lymphocytes within the population of peripheral blood mononuclear cells from subjects studied prior to (baseline), and 2 hr after treatment. Results are presented as means ± SD.

From: Interleukin 2-regulated in vitro antibody production following a single spinal manipulative treatment in normal subjects

Group Phenotype [%]
  CD 19
(range)
CD3
(range)
  Baseline 2 hr Baseline 2 hr
VC 9.2 ± 3
(6 - 14)
10.6 ± 4
(6 - 16)
77 ± 12
(67 - 90)
76 ± 11
(68 - 88)
SMT-NC 10.8 ± 3
(6 - 11)
11.8 ± 5
(7 - 17)
74 ± 14
(64 - 89)
71 ± 16
(58 - 84)
SMT-C 11.0 ± 4
(7 - 15)
11.4 ± 6
(6 - 17)
72 ± 15
(62 - 88)
75 ± 12
(64 - 94)